![Innoplexus-DrD-partnership](https://www.innoplexus.com/wp-content/uploads/2022/04/Innoplexus-DrD-partnership-150x150.jpeg)
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 24
Apr 24
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreFrankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of …
Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the publication of a new study examining consumer perceptions about drug prices, transparency, and other issues related to the pharmaceutical industry. This survey …
Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies Read More »
Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine Intelligence Summit to be held on 14th July 2017, in Berlin, Germany. The panel discussion is around “From Past Learning to Predictive Future” at 13:45 CET on Friday at Deutsche Telekom Hauptstadtrepräsentanz Französische Straße 33a-c, …
Innoplexus @ Machine Intelligence Summit, Berlin 2017 Read More »
As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and truly said, it remains the heart of businesses for life sciences and pharmaceutical industries. A lot still relies upon data while conducting research which is mostly done through traditional methods. As many top notch business …
Accelerating innovation in Pharma with Artificial Intelligence & Big Data Read More »
Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest …
Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexus, and invest in marketing.